World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
47
Citations
10875
World Ranking
4753
National Ranking
1833

Richard Marlink publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard Marlink sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 146 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard Marlink D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Marlink sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard Marlink is affiliated with Rutgers, The State University of New Jersey in the United States. Their research primarily focuses on the field of medicine with a particular emphasis on oncology, epidemiology, and related subfields such as cancer research and hepatology.

The scientist has published extensively on topics including global cancer incidence and screening, hepatitis B and C virus studies, cervical cancer and HPV research, economic and financial impacts of cancer, cancer genomics and diagnostics, as well as HIV/AIDS research and interventions.

Recent publications demonstrate a focus on cancer and infectious diseases in African contexts. Notable papers include:

  • "Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis" (2021, JCO Global Oncology)
  • "Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana" (2020, Medicine)
  • "Advancing oncology drug therapies for sub-Saharan Africa" (2023, PLOS Global Public Health)
  • "Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana" (2020, Pathogens)
  • "Breast cancer patient experiences in the Botswana health system: Is it time for patient navigators?" (2023, Journal of Cancer Policy)

Their collaborative work includes frequent co-authorship with researchers such as Tendani Gaolathe, Peter Vuylsteke, Kirthana Sharma, Refeletswe Lebelonyane, and Reena Antony, reflecting a network of partnerships mainly in infectious disease and cancer research.

Richard Marlink has contributed publications to prominent venues including:

  • JCO Global Oncology
  • Cancer Epidemiology Biomarkers & Prevention
  • Medicine
  • PLOS Global Public Health
  • Frontiers in Microbiology

Best Publications

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes

    Jeffrey S. A. Stringer;Isaac Zulu;Jens Levy;Jens Levy;Elizabeth M. Stringer;Elizabeth M. Stringer

  • Reduced rate of disease development after HIV-2 infection as compared to HIV-1

    Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers

  • Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.

    Sheri Weiser;William Wolfe;William Wolfe;David Bangsberg;Ibou Thior

  • Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

    Ibou Thior;Shahin Lockman;Laura M Smeaton;Roger L Shapiro

  • Slower heterosexual spread of HIV-2 than HIV-1.

    P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex

  • Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression

    Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh

  • HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV

    Luis E. Soto-Ramirez;Boris Renjifo;Mary F. McLane;Richard Marlink

  • New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

    P J Kanki;F Barin;S M'Boup;J S Allan

  • A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

    Bluma Brenner;Dan Turner;Maureen Oliveira;Daniela Moisi

  • Natural protection against HIV-1 infection provided by HIV-2.

    K Travers;S Mboup;R Marlink;A Guèye-Nidaye

  • Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

    Siaka Toure;Bertin Kouadio;Catherine Seyler;Catherine Seyler;Moussa Traore

  • Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design?

    V. Novitsky;U. R. Smith;P. Gilbert;M. F. McLane

  • Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis

    Mansour Farahani;Holly Mulinder;Alexander Farahani;Richard Marlink

  • Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.

    Hermann Bussmann;C William Wester;Ndwapi Ndwapi;Nicolas Grundmann

  • Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection

    V. Novitsky;P. Gilbert;T. Peter;M. F. McLane

  • Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

    Phyllis J. Kanki;Souleymane M'Boup;Dominique Ricard;Francis Barin

  • Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

    William R. Wolfe;S. D. Weiser;D. R. Bangsberg;I. Thior

  • Molecular Cloning and Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana

    Vladimir A. Novitsky;Monty A. Montano;Mary F. McLane;Boris Renjifo

  • Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana

    Natalie T. Do;Kelesitse Phiri;Hermann Bussmann;Tendani Gaolathe

  • Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

    C William Wester;Soyeon Kim;Hermann Bussmann;Ava Avalos

  • Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C

    V. Novitsky;H. Cao;N. Rybak;P. Gilbert

  • Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia

    Jeffrey S. A. Stringer;Isaac Zulu;Elizabeth M. Stringer;Albert Mwango

Frequent Co-Authors

Joseph Makhema
Joseph Makhema Harvard University
Myron Essex
Myron Essex Harvard University
Phyllis J. Kanki
Phyllis J. Kanki Harvard University
Souleymane Mboup
Souleymane Mboup Institute of Health Research, Epidemiological Surveillance and Training
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Tak H. Lee
Tak H. Lee King's College London
Mark A. Wainberg
Mark A. Wainberg McGill University
Brian Foley
Brian Foley Los Alamos National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Microbiology, exploring related online degrees can open diverse career avenues. Programs such as online health information management programs cahiim accredited offer a strong foundation in managing healthcare data, a critical skill in medical and research settings.

If you seek quicker entry into the healthcare field, online medical billing and coding certificate fast programs provide streamlined training to help you start working in administrative roles related to healthcare services efficiently.

Beyond microbiology, aspiring professionals can also consider online medical degrees that offer comprehensive training for various medical careers, some of which can be pursued fully or partially online to accommodate flexible learning schedules.

For public health roles, many students explore easy admission online MPH programs that provide a pathway into community health, epidemiology, and health policy fields, complementing a microbiology background with practical public health expertise.

Best Scientists Citing Richard Marlink

Trending Scientists

Recently Published Articles